Return to Article Details Assessment of Measurable Residual Disease on Day 28 of First Induction Chemotherapy in Acute Myeloid Leukaemia Patients
Themes by Openjournaltheme.com Themes by Openjournaltheme.com Themes by Openjournaltheme.com Themes by Openjournaltheme.com Themes by Openjournaltheme.com